Sourced from:Manufacturer Authorized Distributor
Quick Summary
Jaknat 5mg Tablet
Last updated on 29 Oct 2026 | 06:28 AM (IST)
₹182
MRP: ₹346.88
(You Save ₹164.88)
10 TABLET(s) IN A STRIP
Sourced from:Manufacturer Authorized Distributor
48% OFF
₹182
MRP: ₹346.88
Inclusive of all taxes
48% Off
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.
Substitutes
Intajac 5mg Tablet 14's
INTAS PHARMACEU...
₹ 12.00/tablet
34% cheaper
Intajac 5mg Tablet 10's
INTAS PHARMACEU...
₹ 13.70/tablet
24% cheaper
Jakauto 5mg Tablet
ERIS LIFESCIENC...
₹ 14.20/tablet
21% cheaper
Tofatas 5mg Tablet 14's
INTAS PHARMACEU...
₹ 15.43/tablet
15% cheaper
Better Service Satisfied Customers
Introduction
Jaknat 5mg Tablet contains Tofacitinib 5 mg as its active ingredient. It is a prescription medicine that belongs to a class of medicines called Janus kinase (JAK) inhibitors, which help manage certain inflammatory conditions.
Each film-coated tablet contains Tofacitinib 5 mg, equivalent to Tofacitinib citrate. The medicine affects immune system activity and should be used under medical supervision.
Uses of Jaknat 5mg Tablet
Jaknat 5mg Tablet is used to manage certain inflammatory conditions, including:
Rheumatoid arthritis: Helps reduce joint inflammation, pain, swelling and stiffness.
Psoriatic arthritis: Helps manage joint inflammation and other symptoms associated with this condition.
Ulcerative colitis: Helps control inflammation in the digestive tract in eligible patients.
Ankylosing spondylitis: Helps manage inflammation and symptoms affecting the spine and other joints.
How Jaknat 5mg Tablet Works
Jaknat 5mg Tablet contains Tofacitinib, which inhibits enzymes called Janus kinases (JAKs). These enzymes help transmit signals involved in immune system activity and inflammation.
By blocking these signals, Tofacitinib reduces certain inflammatory responses in the body. This helps control symptoms such as joint pain, swelling and stiffness in inflammatory conditions. In ulcerative colitis, it helps reduce inflammation in the digestive tract.
Interactions of Jaknat 5mg Tablet with Other Medicines
Some medicines can change the amount of Tofacitinib in the body or increase the risk of side effects. Tell your doctor about all prescription medicines, over-the-counter medicines, vitamins and herbal supplements you take.
Strong CYP3A4 inhibitors: Medicines such as ketoconazole can increase Tofacitinib levels in the body. A dose adjustment may be necessary.
CYP3A4 inducers: Medicines such as rifampicin can reduce Tofacitinib levels and may make it less effective.
Immunosuppressants: Medicines such as azathioprine and ciclosporin can increase the risk of excessive immune suppression when used together.
Biological medicines for inflammatory conditions: Combining Tofacitinib with certain biological disease-modifying antirheumatic medicines is generally not recommended because of the increased risk of immunosuppression.
Vaccines: Live vaccines should generally be avoided during treatment. Discuss any planned vaccination with your doctor.
Storage Conditions
Store Jaknat 5mg Tablet at a temperature not exceeding 30°C.
Protect the tablets from moisture.
Keep the medicine in its original packaging until use.
Keep the medicine out of the sight and reach of children.
Do not use the medicine after the expiry date printed on the packaging.
How to Use
Take Jaknat 5mg Tablet exactly as prescribed by your doctor.
Swallow the tablet with water.
It can generally be taken with or without food.
Take the medicine at the prescribed times each day.
Do not change the dose or stop treatment without consulting your doctor.
If you miss a dose, follow your doctor's advice. Do not take a double dose to make up for a missed dose.
Attend scheduled appointments and blood tests to monitor your response to treatment and check for possible side effects.
Safety Advice
Pregnancy
Tofacitinib is generally avoided during pregnancy because available human pregnancy data are limited and animal studies have shown potential risks to the developing baby. Inform your doctor if you are pregnant, planning to become pregnant or become pregnant during treatment. Your doctor will assess the benefits and risks and advise you on suitable treatment options.
Breast Feeding
Breastfeeding is not recommended during treatment with Tofacitinib and for the period advised after the last dose. Discuss suitable feeding options with your doctor before starting treatment if you are breastfeeding.
Lungs
Jaknat 5mg Tablet can increase the risk of serious infections, including tuberculosis and certain respiratory infections. Inform your doctor if you have a history of lung disease, tuberculosis or recurring respiratory infections. Seek prompt medical attention if you develop persistent cough, fever, chest discomfort or difficulty breathing.
Liver
Inform your doctor if you have liver disease or a history of hepatitis. Tofacitinib can affect liver enzyme levels, and blood tests may be needed during treatment. Patients with significant liver impairment may require dose adjustment or an alternative treatment.
Alcohol
Discuss alcohol consumption with your doctor, particularly if you have liver problems or take other medicines that may affect liver function. Your doctor can advise whether alcohol is appropriate for you during treatment.
Driving
Tofacitinib is not generally expected to directly affect your ability to drive. However, avoid driving if you experience dizziness, unusual weakness or any other symptoms that affect your concentration or ability to drive safely.
Side Effects
Jaknat 5mg Tablet may cause side effects in some people, although not everyone experiences them.
Common side effects
Upper respiratory tract infections
Headache
Diarrhoea
Nasopharyngitis (inflammation of the nose and throat)
Nausea
Rash
Increased cholesterol levels
The side effects experienced may vary depending on the condition being treated, the dose and other medicines taken.
Serious side effects
Seek prompt medical attention if you experience symptoms that may indicate a serious adverse reaction, including:
Serious infections: Persistent fever, chills, cough or other signs of infection.
Blood clots: Sudden breathlessness, chest pain or swelling and pain in one leg.
Cardiovascular problems: Chest discomfort, sudden weakness or difficulty speaking.
Blood disorders: Unusual bruising, bleeding, persistent fever or severe fatigue.
Severe allergic reactions: Swelling of the face, lips or throat, or difficulty breathing.
Expert Tips
Take Jaknat 5mg Tablet exactly as prescribed, even if your symptoms improve.
Do not increase, reduce or stop the dose without medical advice.
Attend scheduled blood tests to monitor blood cell counts, liver function and cholesterol levels.
Tell your doctor if you have had tuberculosis, hepatitis or repeated infections before starting treatment.
Report fever, persistent cough or other signs of infection promptly.
Inform your doctor about all medicines and supplements you take to avoid potentially harmful interactions.
Discuss vaccinations with your doctor before receiving any vaccine, particularly live vaccines.
Inform your doctor if you have a history of heart disease, blood clots or cancer.
Seek urgent medical attention if you develop sudden chest pain, breathlessness or swelling in one leg.
Tell your doctor if you are pregnant, planning a pregnancy or breastfeeding before starting treatment.
FAQs
Q1.
What is Jaknat 5mg Tablet used for?
Jaknat 5mg Tablet contains Tofacitinib 5 mg and is used to manage certain inflammatory conditions, such as rheumatoid arthritis, psoriatic arthritis and ulcerative colitis, where the treatment is approved and appropriate. The exact indication depends on the applicable product information and your doctor's assessment.
Q2.
What is the active ingredient in Jaknat 5mg Tablet?
Jaknat 5mg Tablet contains Tofacitinib 5 mg, supplied as Tofacitinib citrate in a film-coated tablet.
Q3.
How should Jaknat 5mg Tablet be taken?
Swallow Jaknat 5mg Tablet with water, following your doctor's prescribed dose and schedule. It can generally be taken with or without food.
Q4.
Can Jaknat 5mg Tablet cause infections?
Yes. Tofacitinib affects immune system activity and can increase the risk of infections, including serious infections such as tuberculosis and shingles. Inform your doctor if you develop fever, a persistent cough or other signs of infection.
Q5.
Can people with liver disease take Jaknat 5mg Tablet?
People with liver disease should consult their doctor before taking Jaknat 5mg Tablet. Liver function may need to be monitored, and patients with significant liver impairment may require a dose adjustment or an alternative treatment.
Q6.
Can Jaknat 5mg Tablet be taken during pregnancy?
Jaknat 5mg Tablet is generally avoided during pregnancy because of potential risks and limited human safety data. Inform your doctor if you are pregnant or planning to become pregnant so that suitable treatment can be discussed.
Q7.
What should I tell my doctor before taking Jaknat 5mg Tablet?
Tell your doctor if you have a history of tuberculosis, recurring infections, liver disease, kidney disease, heart disease, blood clots or cancer. Also disclose all medicines and supplements you take, and inform your doctor if you are pregnant, planning a pregnancy or breastfeeding.
Q8.
What are the common side effects of Jaknat 5mg Tablet?
Common side effects include upper respiratory tract infections, headache, diarrhoea and nasopharyngitis. Other side effects may occur depending on the condition being treated and the individual patient's response.
Q9.
What should I do if I miss a dose of Jaknat 5mg Tablet?
Follow your doctor's instructions if you miss a dose. Do not take a double dose to compensate for the missed tablet.
Q10.
Can Jaknat 5mg Tablet be stopped when symptoms improve?
Do not stop taking Jaknat 5mg Tablet without consulting your doctor. Stopping treatment may cause the underlying inflammatory condition to become active again.
Fact Box
Molecule name | Tofacitinib |
Therapeutic class | Anti-inflammatory and immunomodulatory medicine |
Pharmacological class | Janus kinase (JAK) inhibitor |
Indications | Certain inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and ulcerative colitis, subject to applicable product approval |
References
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Prakruthi Madhusudan
MSc Bioinformatics

Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 29 Oct 2026 | 06:28 AM (IST)

Want to know more?
Read Our Editorial Policy








